Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04260152 · ClinicalTrials.gov registry record · NA
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
A NA study of Gingival Recession, sponsored by Geistlich Pharma.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT04260152 is a NA study of Gingival Recession that has completed, run by Geistlich Pharma. The registered enrollment target is 30 participants, roughly in line with the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target. The trial reports 3 study locations across 3 states.
The verdict
NCT04260152, a NA study of Gingival Recession, has completed, sponsored by Geistlich Pharma.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
This double blind, randomized, split mouth study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for the treatment of Miller Class I or II recession defects at 6 months post treatment.
Conditions Studied
Interventions
- DEVICE Geistlich Fibro-Gide
- PROCEDURE Connective Tissue Graft (CTG
Study Locations (3)
Michigan
- Seven Lakes Periodontitis - Fenton
Texas
- Perio Health Professionals - Houston
Washington
- Oral Health Specialists - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-07-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04260152
The ClinicalTrials.gov registry entry for NCT04260152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target. The listed sponsor is Geistlich Pharma, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which Geistlich Fibro-Gide is the first listed.
NCT04260152 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT04260152 about?
NCT04260152 is a clinical study titled "Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months". This double blind, randomized, split mouth study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for the treatment of Miller Class I or II recession defects at 6 months post treatment.
What is the current status of trial NCT04260152?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-09-01. Estimated completion is 2020-07-22.
What conditions does trial NCT04260152 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT04260152?
The interventions under investigation include: Geistlich Fibro-Gide (DEVICE), Connective Tissue Graft (CTG (PROCEDURE).
Who is sponsoring clinical trial NCT04260152?
This trial is sponsored by Geistlich Pharma, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04260152 being conducted?
This trial has 3 study locations across Michigan, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
-
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.